Using Single-Cell Multiomics To Predict Patients At Risk For Antigen Escape After Car-T Therapy

Using single-cell multiomics to predict patients at risk for antigen escape after CAR-T therapy

VJHemOnc – Video Journal of Hematology & HemOnc

Using Single Cell Multiomics to Accelerate Cancer Immune Cell Therapy Research

Applications in CAR T-Cell Therapy: : Dissecting Cellular Composition Using Single Cell Multiomics.

CurrentProtocols

Overcoming antigen escape following CD19-directed CAR-T therapy

VJHemOnc – Video Journal of Hematology & HemOnc

Expert Tips for Using CAR T-Cell Therapy in Leukemia, Lymphoma, and Multiple Myeloma Care

PeerView Oncology

Single-Cell Genomics in Checkpoint Blockade and CAR-T Cell Immunotherapy

Updates in CAR T Cell Therapies

National Cancer Institute

Activated T cell attacks a cancer cell

Nanolive, Looking inside life

Single-Cell Omics in CAR T-Cell Therapy

ResearchPodcast

Relapsing from CAR T-cells in multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

Using single-cell analysis to tackle myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

What is an antigen escape? #myeloma

HealthTree University for Multiple Myeloma

Treating pediatric ALL with chimeric antigen receptor (CAR) T-cell therapy

VJHemOnc – Video Journal of Hematology & HemOnc

Is CAR T-cell therapy being used to treat newly diagnosed multiple myeloma?

International Myeloma Foundation

Overcoming challenges in CAR T-cell therapy for multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc

CARCIK trial updates: using SB-engineered CAR-T cells in patients with B-ALL

VJHemOnc – Video Journal of Hematology & HemOnc

Advancements and challenges in CAR-T cell therapy

Potential Use of CAR T-Cell Therapy Earlier in Sequencing

Barriers to using CAR T-cells in solid tumors and strategies to overcome them

CAR T-cell therapy for high-risk multiple myeloma

VJHemOnc – Video Journal of Hematology & HemOnc